Evidence map›Paper›PMID 37139772›Full record

ReviewSheng wu yi xue gong cheng xue za zhi = Journal of biomedical engineering = Shengwu yixue gongchengxue zazhi2023

[Surface modification of multifunctional ferrite magnetic nanoparticles and progress in biomedicine].

Linxue Zhang, Nuernisha Alifu, Zhongwen Lan, Zhong Yu, Qifan Li, Xiaona Jiang, Chuanjian Wu, Ke Sun

Abstract readEnglish AbstractReview
In one paragraph

Review in Sheng wu yi xue gong cheng xue za zhi = Journal of biomedical engineering = Shengwu yixue gongchengxue zazhi, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Linxue ZhangSchool of Materials and Energy, University of Electronic Science and Technology of China, Chengdu 610054, P. R. China.
Nuernisha AlifuSchool of Medical Engineering and Technology, Xinjiang Medical University, Urumqi 830017, P. R. China.
Zhongwen LanSchool of Materials and Energy, University of Electronic Science and Technology of China, Chengdu 610054, P. R. China.
Zhong YuSchool of Materials and Energy, University of Electronic Science and Technology of China, Chengdu 610054, P. R. China.
Qifan LiSchool of Materials and Energy, University of Electronic Science and Technology of China, Chengdu 610054, P. R. China.
Xiaona JiangSchool of Materials and Energy, University of Electronic Science and Technology of China, Chengdu 610054, P. R. China.
Chuanjian WuSchool of Materials and Energy, University of Electronic Science and Technology of China, Chengdu 610054, P. R. China.
Ke SunSchool of Materials and Energy, University of Electronic Science and Technology of China, Chengdu 610054, P. R. China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Magnetic ferrite nanoparticles (MFNPs) have great application potential in biomedical fields such as magnetic resonance imaging, targeted drugs, magnetothermal therapy and gene delivery. MFNPs can migrate under the action of a magnetic field and target specific cells or tissues. However, to apply MFNPs to organisms, further modifications on the surface of MFNPs are required. In this paper, the common modification methods of MFNPs are reviewed, their applications in medical fields such as bioimaging, medical detection, and biotherapy are summarized, and the future application directions of MFNPs are further prospected.

Indexed as

Magnetite NanoparticlesNanoparticlesFerric CompoundsMagnetic Resonance ImagingMagneticsFerric CompoundsferriteMagnetite NanoparticlesBioimagingBiotherapyFerriteTargeting

Identifiers

PMID37139772
PMCPMC10162916

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.